Antibody Stability Optimization

Antibody stability optimization is a key aspect of biotherapeutic development, influencing the efficacy, immunogenicity, and pharmacokinetic profile of antibodies. Ensuring the stability of antibodies is crucial for their successful clinical and commercial applications. At CD ComputaBio, we offer a comprehensive suite of services that leverage AI to address challenges surrounding antibody stability, to deliver high-quality, stable antibodies for therapeutic use. Our commitment to advancing drug development has led us to pioneer cutting-edge solutions through the application of Artificial Intelligence (AI) in optimizing antibody stability. Through our innovative methods, we aim to enhance the efficacy and safety profile of antibodies, contributing to the advancement of biopharmaceutical products that have the potential to revolutionize patient care.

Our Services

Fig 1: Antibody general structure

Computational Assessment of Antibody Stability

Utilizing advanced computational tools, our experts analyze the structural properties of antibodies to predict and assess their stability under various conditions. By examining key factors such as conformational flexibility, aggregation propensity, and thermal stability, we provide valuable insights into antibody behavior, enabling informed decisions in the drug development process.

Fig 2: Simplified scheme of protein degradation and aggregation pathways.

Rational Antibody Design

Through AI-guided molecular modeling and simulation, we facilitate the rational design of antibodies with enhanced stability profiles. Our approach enables the exploration of diverse antibody sequences and structural modifications to tailor stability characteristics, ultimately improving the overall performance and safety of the therapeutic antibodies.

Our Analysis Methods

Key methodologies include:

Our Stability Optimization Strategies

We develop customized strategies to optimize antibody stability, employing a multidisciplinary approach that integrates computational modeling, machine learning, and molecular dynamics simulations. This comprehensive strategy allows us to systematically enhance antibody stability while maintaining its binding affinity and specificity.

Result Delivery

At CD ComputaBio, we are committed to delivering actionable insights and tangible outcomes to our clients. Upon completion of our antibody stability optimization services, clients can expect:

  • Comprehensive stability reports
  • Data-driven Insights
  • Strategic recommendations

CD ComputaBio comprises experts in computational biology, bioinformatics, structural biology, and machine learning, bringing together diverse skill sets to address the complexity of antibody stability optimization. If you are interested in our services or have any questions, please feel free to contact us.


  • Le Basle Y, Chennell P, Tokhadze N, et al. Physicochemical stability of monoclonal antibodies: a review[J]. Journal of Pharmaceutical Sciences, 2020, 109(1): 169-190.
  • Kuzman D, Bunc M, Ravnik M, et al. Long-term stability predictions of therapeutic monoclonal antibodies in solution using Arrhenius-based kinetics[J]. Scientific reports, 2021, 11(1): 20534.


Online Inquiry

CD ComputaBio

Copyright © 2024 CD ComputaBio Inc. All Rights Reserved.